tiprankstipranks
Rubius Therapeutics (RUBY)
OTHER OTC:RUBY
US Market

Rubius Therapeutics (RUBY) Stock Investors

220 Followers
Based on 709,557 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold RUBY
On average, investors allocate 0.00% of their portfolios to RUBY
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 709,557 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding RUBY

1.0%
Last 7
Days
3.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding RUBY, out of 709,557 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

RUBY Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$0.02
Based on the activity of 13,147 investors who made their portfolios public
The table shows changes in RUBY in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

RUBY Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.53%
-0.73%
+0.31%
343.00M
Healthcare
Micron
5.50%
+1.67%
+8.54%
93.78B
Technology
Snap
9.84%
-0.89%
-1.00%
28.50B
Communication Services
Block
4.51%
-0.31%
+1.47%
42.56B
Technology
Qualcomm
4.74%
-0.30%
-0.58%
154.74B
Technology
Merck & Company
4.29%
+0.30%
+2.82%
297.44B
Healthcare
Assertio Therapeutics
2.69%
+0.30%
-2.60%
91.36M
Healthcare
Salesforce
4.95%
+0.37%
+3.42%
252.52B
Technology
International Business Machines
5.69%
+0.10%
+1.71%
147.14B
Technology
AMC Entertainment
5.40%
-0.68%
-1.58%
1.05B
Communication Services
Based on the activity of 709,557 active portfolios
Open your Smart Portfolio

RUBY Investor Analysis

RUBY investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
20.0%
of RUBY holders
are under 35
Average Segment Performance
Average P/E Ratio12.78
Beta7.19
Dividend Yield5.61%
RUBY investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.0%
of RUBY holders
are between 35–55
Average Segment Performance
Average P/E Ratio8.89
Beta11.01
Dividend Yield5.81%
RUBY investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
40.0%
of RUBY holders
are over 55
Average Segment Performance
Average P/E Ratio7.23
Beta5.80
Dividend Yield5.74%
Overview of age group and performance of RUBY stock investors
See who invests in RUBY according to age group and performance.

FAQ

How many retail Investors hold RUBY?
<0.1% of TipRanks' retail investors hold RUBY in their portfolios.
    What is RUBY Investor Sentiment?
    RUBY’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of RUBY in the last 7 days?
      ▼ 1.0% of TipRanks' retail investors changed their holding of RUBY in the last 7 days.
        What percentage of retail investors changed their holding of RUBY in the last 30 days?
        ▼ 3.6% of TipRanks' retail investors changed their holding of RUBY in the last 30 days.
          What is the average age of retail investors who hold RUBY?
          The average age of RUBY Holders is over 55.
            What other stocks have RUBY investors also bought?
            RUBY Investors also bought CHRS, MU, SNAP, SQ, QCOM, MRK, ASRT, CRM, IBM, AMC.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ATECAlphatec Holdings
              AZNAstraZeneca
              BCRXBioCryst
              BIIBBiogen
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis